CU6 — Clarity Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$1.41bn
- AU$1.37bn
- 31
- 17
- 93
- 46
2020 June 30th | C2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Changes in Working Capital | 2.01 | 2.56 | 3.34 | 8.31 |
Other Operating Cash Flow | ||||
Cash from Operating Activities | -6.83 | -7.68 | -13.3 | -27.5 |
Capital Expenditures | -0.015 | -0.06 | -0.213 | -0.047 |
Purchase of Fixed Assets | ||||
Other Investing Cash Flow Items | — | -9.5 | -26.5 | 3.2 |
Change in Net Investments | ||||
Cash from Investing Activities | -0.015 | -9.56 | -26.7 | 3.15 |
Financing Cash Flow Items | 3.52 | -0.681 | -5.6 | -0.013 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Cash from Financing Activities | 8.22 | 20.4 | 86.9 | 0.232 |
Foreign Exchange Effects | ||||
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 1.37 | 3.17 | 46.9 | -24.1 |